Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|February 13, 2018
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastasesBart A W Jacobs, Nikol Snoeren, Morsal Samim, et al.
NMR in Biomedicine|September 17, 2015
(19)F MRSI of capecitabine in the liver at 7 T using broadband transmit-receive antennas and dual-band RF pulsesJetse S van Gorp, Peter R Seevinck, Anna Andreychenko, et al.
British Journal of Cancer|May 20, 2024
Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximabKoen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, et al.
JNCI Cancer Spectrum|August 10, 2021
Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection WavesJeroen W G Derksen, Anne M May, Lonneke V van de Poll-Franse, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancerJohannes J M Kwakman, Rob C M van Kruijsdijk, Sjoerd G Elias, et al.
Oncotarget|September 23, 2015
MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancerFemke Simmer, Sabine Venderbosch, Jeroen R Dijkstra, et al.
EJNMMI Research|September 22, 2020
Mode of progression after radioembolization in patients with colorectal cancer liver metastasesCaren van Roekel, Jennifer M J Jongen, Maarten L J Smits, et al.
Gut|January 24, 2012
Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancerLeonie J M Mekenkamp, Josien C Haan, Miriam Koopman, et al.
Cancers|November 13, 2021
Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic TherapyEmre Küçükköse, G Emerens Wensink, Celine M Roelse, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|February 13, 2018
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastasesBart A W Jacobs, Nikol Snoeren, Morsal Samim, et al.
NMR in Biomedicine|September 17, 2015
(19)F MRSI of capecitabine in the liver at 7 T using broadband transmit-receive antennas and dual-band RF pulsesJetse S van Gorp, Peter R Seevinck, Anna Andreychenko, et al.
British Journal of Cancer|May 20, 2024
Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximabKoen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, et al.
JNCI Cancer Spectrum|August 10, 2021
Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection WavesJeroen W G Derksen, Anne M May, Lonneke V van de Poll-Franse, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancerJohannes J M Kwakman, Rob C M van Kruijsdijk, Sjoerd G Elias, et al.
Oncotarget|September 23, 2015
MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancerFemke Simmer, Sabine Venderbosch, Jeroen R Dijkstra, et al.
EJNMMI Research|September 22, 2020
Mode of progression after radioembolization in patients with colorectal cancer liver metastasesCaren van Roekel, Jennifer M J Jongen, Maarten L J Smits, et al.
Gut|January 24, 2012
Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancerLeonie J M Mekenkamp, Josien C Haan, Miriam Koopman, et al.
Cancers|November 13, 2021
Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic TherapyEmre Küçükköse, G Emerens Wensink, Celine M Roelse, et al.
British Journal of Cancer|November 3, 2018
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataAnne Trinh, Claudia Lädrach, Heather E Dawson, et al.
Pageof 20